Skip to main content UK The UK's free public sector contract intelligence platform. 160,000+ live opportunities from every official UK procurement portal.
PA23 Ready UK Data Daily Updates
BidWriter Found a contract? BidWriter drafts, scores and manages the bid — AI bid writing from your own evidence.
eSourcing OS For buyers. The platform contracting authorities run their tenders, frameworks and DPS on.
See eSourcing OS → 🇺🇸 WinAContract InternationalBidding on US federal & state contracts? Use our American platform:
© 2026 eSourcing Data Ltd · Company No. 16391108 Registered in England & Wales
Data sourced under Crown Copyright from official UK government portals 🇬🇧
Loading contract search results…
Loading contract details…
#2c3e50#3aaee0
Awarded: NHS National Generic Pharmaceuticals Wave 14a | Sandoz Ltd | WinAContract
NHS National Generic Pharmaceuticals Wave 14a Public Sector Award notice Closed SME-friendly
Source: Contracts Finder Notice Type: Award notice Buyer: NHS England Main Category: Goods Procurement Method: Open procedure (below threshold) Tender Status: Closed Estimated Value (ex. VAT):
Award outcome Awarded to (99 suppliers)
Sandoz Ltd GB-CFS-165043
Amarox Limited GB-CFS-188189
Synchrony GB-CFS-215233
Mylan GB-CFS-215197
Lupin Healthcare (UK) Limited GB-CFS-215229
Torbay Pharmaceuticals GB-CFS-215222
Lucane Pharma GB-CFS-215236
Celix Pharma Ltd. GB-CFS-216260
Fresenius Kabi Limited GB-CFS-181853
Mercury Pharmaceuticals Limited
Description Invitation to offer for NHS National Generic Pharmaceuticals Wave 14a
Offer reference number: CM/PHG/22/5657
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Hospital Only Products: DLN & DNW 01/02/2023 - 31/01/2025 (24 Months)
Housekeeping Products (Hospital Only): CESW 01/02/2023 - 30/09/2023 (8 Months) LSNE 01/02/2023 - 31/05/2024 (16 Months)
About NHS England Published contracts in the last 12 months
£251,986,446
average contract size
Typical categories
Education and training services Medical equipments, pharmaceuticals and personal care products
Add to pipelineImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Save Alert me Share this contractApplication Deadline
18 October 2022
Closed
Estimated Value
£562,201,004
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation → Release Date: 18 January 2023
Application Deadline: 18 October 2022
Contract Start Date: 1 February 2023
Contract End Date: 31 January 2025
Contract Duration: 2.0 years
Procurement ID (OCID): ocds-b5fd17-6e19d30d-423d-4c0d-9490-3367cb99ed30
Notice Reference: 88eb8a5f-961e-4386-8526-16b609f6b817-606795
View Original Notice
Access the full notice on the official portal
GB-CFS-209849
Milpharm Ltd/aurobinbdo GB-CFS-215224
GlaxoSmithKline UK Limited GB-CFS-198842
medac Pharma LLP GB-CFS-186546
Macure Pharma ApS GB-CFS-232994
Teva UK Limited GB-CFS-165044
Sun Pharma UK Ltd GB-CFS-232995
Wockhardt UK Limited GB-CFS-186547
Morningside Pharmaeuticals GB-CFS-232996
Neon Healthcare Ltd GB-CFS-215237
Flexipharm Austrading Limited GB-CFS-215219
Martindale Pharma GB-CFS-215189
Gerot Lannach UK Ltd GB-CFS-226311
Roche Products Ltd GB-CFS-215212
Thornton and Ross Ltd GB-CFS-216210
Aventis Pharma ltd t/a Sanofi GB-CFS-183752
Pierre Fabre Ltd GB-CFS-215205
Kent Pharma Ltd GB-CFS-216262
FLYNN PHARMA LTD GB-CFS-232997
Zentiva Pharma UK Ltd GB-CFS-165046
CST Pharma Limited GB-CFS-183757
Intrapharm Laboratories Ltd GB-CFS-209842
B. Braun Medical Limited GB-CFS-181856
Glenmark Pharmaceuticals Europe Limited GB-CFS-186544
ennogen healthcare ltd GB-CFS-209845
Desitin Pharma Ltd GB-CFS-215201
Thea Pharmaceuticals Limited GB-CFS-232999
Selective Supplies Ltd. GB-CFS-209835
Baxter Healthcare Ltd GB-CFS-181854
ROVI Biotech Ltd GB-CFS-233000
Stirling Anglian Pharmaceuticals Ltd GB-CFS-209874
Aguettant Ltd GB-CFS-209853
Dr.Reddy's Laboratories (UK) Limited GB-CFS-233001
Tillomed Laboratories ltd GB-CFS-186545
Aspire Pharma Limited GB-CFS-215203
Macleods Pharma UK Limited GB-CFS-215198
Panpharma UK Limited GB-CFS-233002
Janssen-Cilag Ltd GB-CFS-165041
Lundbeck Limited GB-CFS-215217
Colonis Pharma Ltd GB-CFS-209855
Crescent Pharma Ltd GB-CFS-215225
Aspen Pharmacare UK Limited GB-CFS-233003
Seacross Pharmaceuticals Ltd GB-CFS-215228
MSN Laboratories Europe Limited GB-CFS-233005
AOP Orphan Ltd GB-CFS-233006
Consilient Health Ltd GB-CFS-215191
hameln pharma ltd GB-CFS-215188
Day Lewis Medical Ltd GB-CFS-215215
Recordati Pharmaceuticals Ltd GB-CFS-233008
Brown & Burk UK Ltd GB-CFS-215227
Accord-UK Ltd GB-CFS-165037
Arcadia Pharma Ltd T/A Arcadia Medical GB-CFS-233009
MIP Pharma GmbH GB-CFS-233011
Bowmed Ibisqus Limited GB-CFS-215193
Sobi (Swedish Orphan Biovitrum Ltd) GB-CFS-233012
Ferring Pharmaceuticals Ltd GB-CFS-183751
Bausch + Lomb (Pharma) GB-CFS-233013
Neuraxpharm UK Ltd GB-CFS-233014
Correvio GmbH GB-CFS-233015
Manx Healthcare Ltd GB-CFS-215211
GH Pharma Ltd GB-CFS-233016
Piramal Critical care Limited GB-CFS-181857
Vantage Pharmaceuticals Ltd GB-CFS-233018
Aristo Pharma Limited GB-CFS-215232
Laboratorio Reig Jofre SA GB-CFS-215192
Drugsrus Ltd GB-CFS-209844
Chiesi Limited GB-CFS-186555
Otsuka Pharmaceuticals UK Limited GB-CFS-233019
Takeda UK Ltd GB-CFS-183750
Waverley Pharma Europe Limited GB-CFS-233020
Tetris Pharma Lts GB-CFS-233021
Ascend Laboratories UK Ltd GB-CFS-215240
Beaumont Pharma Ltd GB-CFS-233022
Focus Pharmaceuticals Ltd GB-CFS-209884
Bristol Myers Squibb GB-CFS-233024
RPH Pharmaceuticals AB GB-CFS-215223
Kensington Pharma Ltd GB-CFS-215195
Strides Pharma Uk LTD GB-CFS-209875
LogixX Pharma Ltd GB-CFS-215216
Torrent Pharma UK Ltd GB-CFS-209882
Award value: £207,982,407 Award decision date: 14 December 2022 Award status: Active